PMID: 23934925

Rab A, Rowe SM, Raju SV, Bebok Z, Matalon S, Collawn JF
Cigarette smoke and CFTR: implications in the pathogenesis of COPD.
Am J Physiol Lung Cell Mol Physiol. 2013 Oct 15;305(8):L530-41. doi: 10.1152/ajplung.00039.2013. Epub 2013 Aug 9., [PubMed]
Sentences
No. Mutations Sentence Comment
68 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:68:29
status: NEW
view ABCC7 p.Gly551Asp details
Similarly, another mutation, G551D, yields a protein that is transported to the cell surface but is unable to transport anions and thus has a channel-gating defect. Login to comment
69 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:69:98
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 23934925:69:90
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Arg553*
X
ABCC7 p.Arg553* 23934925:69:138
status: NEW
view ABCC7 p.Arg553* details
ABCC7 p.Asn1303Lys
X
ABCC7 p.Asn1303Lys 23934925:69:126
status: NEW
view ABCC7 p.Asn1303Lys details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 23934925:69:83
status: NEW
view ABCC7 p.Gly542* details
Only six other mutations have a frequency of greater than 1% in the CF population (G542X, W1282X, G551D, 621 af9; G&#a1;T, N1303K, and R553X) (157). Login to comment
71 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:71:101
status: NEW
view ABCC7 p.Gly551Asp details
Although there is no cure for CF, current therapies, particularly with regard to the gating mutants (G551D and others), are highly effective toward augmenting CFTR function and improving clinical outcome (5, 48, 120, 151). Login to comment
123 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:123:390
status: NEW
view ABCC7 p.Gly551Asp details
ABCC7 p.Trp1282*
X
ABCC7 p.Trp1282* 23934925:123:314
status: NEW
view ABCC7 p.Trp1282* details
ABCC7 p.Gly542*
X
ABCC7 p.Gly542* 23934925:123:307
status: NEW
view ABCC7 p.Gly542* details
Alternative approaches have included high-throughput screens to identify small molecules that promote either 1) F508del CFTR rescue and delivery to the cell surface (108), 2) read-through of premature stop mutations to override nonsense mutations and help translation to produce full-length proteins (e.g., G542X, W1282X, etc.) (160), or 3) potentiation of channel-gating mutations such as G551D (151). Login to comment
183 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:183:132
status: NEW
view ABCC7 p.Gly551Asp details
The discovery of potent CFTR activators such as ivacaftor for CF patients with CFTR mutations leading to functional defects such as G551D and the observed CFTR dysfunction seen in COPD patients prompted some investigators to test the compound for both disorders (138). Login to comment
211 ABCC7 p.Gly551Asp
X
ABCC7 p.Gly551Asp 23934925:211:109
status: NEW
view ABCC7 p.Gly551Asp details
demonstrated that wild-type CFTR expression could also attenuate proinflammatory cytokine secretion, whereas G551D CFTR could not, indicating that chloride channel activity was necessary for this effect (152). Login to comment